Follow on Google News News By Tag * Biobanking * Sample Management * DNA samples * Personalised Medicine * Stem Cells * Biomarkers * Cryostore * Drug Discovery * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Biobanking - Collaborating for Global R&D and InvestmentSMi’s Biobanking conference, taking place in London, 11th & 12th July 2011, is the perfect opportunity to network with the industry’s leading figures and contribute to the successful future of drug discovery.
By: SMi Group Despite financial austerity, the UK government have committed large sums of money into developing technologies and coupled with the US investing over $1billion dollars in the last ten years, there is a clear increase in the number and value of biobanks. Like other R&D initiatives, however, biobanks require continual investment to expand and develop their research and ultimately, the value of the information stored in biobanks is dependent on the investment continuing. Despite unquestionable commercial growth opportunities there are still a number of barriers which need to be overcome. Biobanks need to deliver quality samples for biomarker discovery and personalised medicine, however who is best placed to ensure this; should Biobanks be self regulating or have an independent certified organisation develop a system of accreditation? Biobanking is the perfect forum to debate and analyse the challenges when providing quality in long term storage. SMi’s post-conference workshop, focusing on the practicalities in operating biobanks, is the perfect opportunity to explore best practices from new and established biobanks and much much more. Register your attendance today and join a group of like-minded industry professionals to explore the future of biobanking. SMi have bought together a number of senior academic and industry speakers to focus on the following: •Enforcing standardisation on a global scale; benefits across the board will be hugely valuable! •Utilising biobanks for research and development; •Regenerative medicines – putting it all into practice •Managing biobanks – overcoming current challenges and planning for the future •Informatics; Our key note speakers include: •Julia Corfield, Biobank Head, AstraZeneca •George Tokiwa, Associate Scientific Director, Merck •Dr Rivka Ravid, Senior Scientist, Royal Dutch Academy of Sciences, Brain Bank Consultants •Nigel Spurr, Biomarker Expert, Roche •Dr Sven Kili, Global Medical Director – Cell Therapy & Regenerative Medicine, Genzyme •David Pulford, Investigator Genertics Capabilities for EU & Asia / Japan, GlaxoSmithKline For further information regarding the full speaker line-up, conference programme and the opportunity to register online please visit; http://www.smi- Latest registrations include: **Karolinska Institutet* *Roche Products* *Ipsen* *Marken* *I-path Diagnostics* # # # SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information. End
Account Email Address Disclaimer Report Abuse
|
|